Global Health · NSE: MEDANTA · BSE: 543654
Q1 FY25 results · Apr–Jun 2024
Global Health reported revenue from operations of ₹861.08 crore (up 11.4% from Q1 FY24) and net profit of ₹106.26 crore (up 4.2% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 861.08 | 773.04 | +11.4% | 808.63 | +6.5% |
| Other income | 21.93 | 21.46 | +2.2% | 27.42 | −20.0% |
| Total income | 883.00 | 794.50 | +11.1% | 836.05 | +5.6% |
| Profit before tax | 143.65 | 141.04 | +1.9% | 143.09 | +0.4% |
| Net profit for the period | 106.26 | 102.01 | +4.2% | 127.35 | −16.6% |
| Attributable to shareholders of the company | 106.29 | — | — | 127.38 | −16.6% |
| EPS, basic (₹) | 3.96 | 3.80 | +4.2% | 4.74 | −16.5% |
| Net margin (%) | 12.3 | 13.2 | 15.7 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 611.45 | 544.59 | +12.3% | 578.64 | +5.7% |
| Other income | 26.70 | 33.20 | −19.6% | 32.55 | −18.0% |
| Total income | 638.15 | 577.79 | +10.4% | 611.19 | +4.4% |
| Profit before tax | 129.74 | 115.74 | +12.1% | 125.17 | +3.7% |
| Net profit for the period | 96.28 | 86.21 | +11.7% | 92.24 | +4.4% |
| EPS, basic (₹) | 3.58 | 3.21 | +11.5% | 3.43 | +4.4% |
| Net margin (%) | 15.7 | 15.8 | 15.9 |
Consolidated
- Filed with BSE
- 09 Aug 2024, 14:35 IST
- Board meeting
- 08 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Aug 2024, 14:35 IST
- Board meeting
- 08 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE